KG, Nmbrecht, Germany) and heparin syringes (Werfen, Kirchheim, Germany) at the following timepoints: d 110 pp (= 1 d ai ), d 111 pp (LPS injection) at 0.5, 1, 2, 3, 4, 6, 9, 12, 24, 48 and 72 h pi , d 118 pp (= 7 d pi ), and d 126 pp (= 14 d pi )
doi: 10.1016/j.canlet.2022.215837 69 WuZFangYWuJWangJLingYLiuTet al
Cagrilintide (trials): once-weekly subcutaneous administration, escalated gradually over roughly six weeks to limit gastrointestinal effects
These agents have demonstrated potential in preclinical models and clinical trial studies for modulating glycinergic neurotransmission, suggesting their potential as therapeutic strategies for a variety of neurological and psychiatric disorders
J Neurochem 129:649662
Collectively, these structural degenerative changes, along with functional compensatory mechanisms and dysfunctions, constitute the neural basis for cognitive decline in older adults